Determinants of mortality in non-neutropenic ICU patients with candidaemia.
Open accessThe DOI matches its Crossref record; 24 of the 25 references it cites were found in a registry or an index.
Abstract
Introduction: Candidaemia in critically-ill intensive care unit (ICU) patients is associated with high crude mortality. Determinants of mortality – particularly those amenable to potential modification – are incompletely defined. Methods: A nationwide prospective clinical and microbiological cohort study of all episodes of ICU-acquired candidaemia occurring in non-neutropenic adults was undertaken in Australian ICUs between 2001 and 2004. Multivariate Cox regression analyses were performed to determine independently significant variables associated with mortality. Results: 183 episodes of ICU-acquired candidaemia occurred in 183 patients during the study period. Of the 179 with microbiological data, Candida albicans accounted for 111 (62%) episodes and Candida glabrata, 32 (18%). Outcome data were available for 173: crude hospital mortality at 30 days was 56%. Host factors (older age, ICU admission diagnosis, mechanical ventilation and ICU admission diagnosis) and failure to receive systemic antifungal therapy were significantly associated with mortality on multivariate analysis. Among the subset who received initial fluconazole therapy (n = 93), the crude mortality was 52%. Host factors (increasing age and haemodialysis receipt), but not organism- (Candida species, fluconazole MIC), pharmacokinetic- (fluconazole dose, time to initiation), or pharmacodynamic-related parameters (fluconazole dose:MIC ratio) were associated with mortality. Process of care measures advocated in recent guidelines were implemented inconsistently: follow-up blood cultures were obtained in 68% of patients, central venous catheters removed within five days in 80% and ophthalmological examination performed in 36%. Conclusions: Crude mortality remains high in Australian ICU patients with candidaemia and is overwhelmingly related to host factors but not treatment variables (the time to initiation of antifungals or fluconazole pharmacokinetic and pharmacodynamic factors). The role and timing of early antifungal intervention in critically-ill ICU patients requires further investigation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“The mortality reduction associated with early antimicrobials appears strongest in patients with septic shock, where studies have reported a strong association between time to antibiotics and death in patients with septic shock but weaker associations in patients without septic shock (98,109,110).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [110]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In patients with sepsis without shock, the association between time to antimicrobials and mortality within the first few hours from presentation is less consistent (98, 110).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [110]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Some observational studies suggested that prompt initiation of appropriate empiric antifungal therapy may be associated with a reduction in mortality, however these studies do not prove a causal relationship between antifungal therapy and outcome, nor do they clarify the role of timing of treatment, and some other studies have failed to show this association [167, 171–173].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [172]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In a study of 35,000 patients treated at Kaiser Permanente Northern California, each additional hour of time from ER arrival to administration of antimicrobials was associated with 1.09 increased odds of in-hospital mortality (1.07 for patients with”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [110]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
Levy, M. M., Fink, M. P., Marshall, J. C., Abraham, E., Angus, D., Cook, D., Cohen, J., Opal, S. M., Vincent, J.-L., & Ramsay, G. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000050454.01978.3b · Cited by 5,995
Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B. (2004) · Clinical Infectious Diseases · doi:10.1086/421946 · Cited by 4,496 · cited 1×
“Introduction Candidaemia is a relatively common healthcare-associated infection in critically-ill patients in intensive care units (ICUs) [1-3] that is associated with poor clinical outcomes and excess economic costs [4,5].”
BackgroundPappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191 · cited 1×
“Despite the availability of new antifungal agents and management guidelines [6], candidaemia remains associated with persistently high crude mortality rates.”
BackgroundDurack, D. T., Lukes, A. S., Bright, D. K., & Service, D. E. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90143-0 · Cited by 2,572
Nosocomial infections in medical intensive care units in the United States
Richards, M. J., Edwards, J. R., Culver, D. H., & Gaynes, R. P. (1999) · Critical Care Medicine · doi:10.1097/00003246-199905000-00020 · Cited by 1,565
Guidelines for Treatment of Candidiasis
Pappas, P. G., Rex, J. H., Sobel, J. D., Filler, S. G., Dismukes, W. E., Walsh, T. J., & Edwards, J. E. (2004) · Clinical Infectious Diseases · doi:10.1086/380796 · Cited by 1,440 · cited 5×
“Authoritative guidelines, such as those published by the IDSA [21] and the Australasian Society for Infectious Diseases [22], suggest a number of quality improvement ancillary measures which aim to improve the outcome of candidaemia.”
BackgroundInfluentialMorrell, M., Fraser, V. J., & Kollef, M. H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.9.3640-3645.2005 · Cited by 1,286
Garey, K. W., Rege, M., Pai, M. P., Mingo, D. E., Suda, K. J., Turpin, R. S., & Bearden, D. T. (2006) · Clinical Infectious Diseases · doi:10.1086/504810 · Cited by 1,171 · cited 5×
“In contrast, the other relevant study [8] did demonstrate increases in mortality for delays measured in 24-hour increments.”
BackgroundResultInfluentialNosocomial Infections in Combined Medical-Surgical Intensive Care Units in the United States
Richards, M. J., Edwards, J. R., Culver, D. H., Gaynes, R. P., & System, N. N. I. S. (2000) · Infection Control & Hospital Epidemiology · doi:10.1086/501795 · Cited by 1,028
Epidemiology of Candida species infections in critically ill non-immunosuppressed patients
Eggimann, P., Garbino, J., & Pittet, D. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00801-6 · Cited by 900
Research works printed but not linked: 1
- National Committee for Clinical Laboratory Standards: Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved Standard, 2nd edition. M27-A2. Wayne, Pa.: National Committee for Clinical Laboratory Standards; 2002.
Cited by
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082
Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005337 · Cited by 2,935
Kett, D. H., Azoulay, E., Echeverria, P. M., & Vincent, J.-L. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e318206c1ca · Cited by 389
Epidemiology of invasive candidiasis
Arendrup, M. C. (2010) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e32833e84d2 · Cited by 376
Resistance to antifungals that target CYP51
Parker, J. E., Warrilow, A. G. S., Price, C. L., Mullins, J. G. L., Kelly, D. E., & Kelly, S. L. (2014) · Journal of Chemical Biology · doi:10.1007/s12154-014-0121-1 · Cited by 204
Colombo, A. L., Guimarães, T., Sukienik, T., Pasqualotto, A. C., Andreotti, R., Queiroz-Telles, F., Nouér, S. A., & Nucci, M. (2014) · Intensive Care Medicine · doi:10.1007/s00134-014-3400-y · Cited by 183
Diagnostic Issues, Clinical Characteristics, and Outcomes for Patients with Fungemia
Arendrup, M. C., Sulim, S., Holm, A., Nielsen, L., Nielsen, S. D., Knudsen, J. D., Drenck, N. E., Christensen, J. J., & Johansen, H. K. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00179-11 · Cited by 178
Impact of Therapeutic Strategies on the Prognosis of Candidemia in the ICU*
Puig-Asensio, M., Pemán, J., Zaragoza, R., Garnacho-Montero, J., Martín-Mazuelos, E., Cuenca-Estrella, M., & Almirante, B. (2014) · Critical Care Medicine · doi:10.1097/ccm.0000000000000221 · Cited by 147
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2026
Prescott, H. C., Antonelli, M., Alhazzani, W., Møller, M. H., Alshamsi, F., Azevedo, L. C. P., Belley-Cote, E., De Waele, J., Derde, L., Dionne, J. C., et al. (2026) · Intensive Care Medicine · doi:10.1007/s00134-026-08361-1 · Cited by 141
Surviving Sepsis campaign: international guidelines for Management of Sepsis and Septic Shock 2026
Prescott, H. C., Antonelli, M., Alhazzani, W., Møller, M. H., Alshamsi, F., Azevedo, L. C. P., Belley-Cote, E., De Waele, J., Derde, L., Dionne, J. C., et al. (2026) · Critical Care Medicine · doi:10.1097/ccm.0000000000007075 · Cited by 117
Garnacho-Montero, J., Diaz-Martin, A., Garcia-Cabrera, E., Ruiz Perez de Pipaon, M., Hernandez-Caballero, C., & Lepe-Jimenez, J. A. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks347 · Cited by 112
Jacobsen, I. D., Brunke, S., Seider, K., Schwarzmüller, T., Firon, A., d'Enfért, C., Kuchler, K., & Hube, B. (2010) · Infection and Immunity · doi:10.1128/iai.01244-09 · Cited by 101
Antifungal therapy in invasive fungal infections
Chen, S. C. ‐., Playford, E. G., & Sorrell, T. C. (2010) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2010.06.002 · Cited by 109
Self-citationInvasive candidiasis in intensive care units in China: a multicentre prospective observational study
Guo, F., Yang, Y., Kang, Y., Zang, B., Cui, W., Qin, B., Qin, Y., Fang, Q., Qin, T., Jiang, D., et al. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt083 · Cited by 92
Paiva, J.-A., Pereira, J. M., Tabah, A., Mikstacki, A., de Carvalho, F. B., Koulenti, D., Ruckly, S., Çakar, N., Misset, B., Dimopoulos, G., et al. (2016) · Critical Care · doi:10.1186/s13054-016-1229-1 · Cited by 84
Aguado, J. M., Ruíz-Camps, I., Muñóz, P., Mensa, J., Almirante, B., Vázquez, L., Rovira, M., Martín‐Dávila, P., Moreno, A., Álvarez-Lerma, F., et al. (2011) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2011.01.008 · Cited by 94
Macauley, P., & Epelbaum, O. (2021) · Mycoses · doi:10.1111/myc.13258 · Cited by 78
Occurrence, presentation and treatment of candidemia
Mikulska, M., Del Bono, V., Ratto, S., & Viscoli, C. (2012) · Expert Review of Clinical Immunology · doi:10.1586/eci.12.52 · Cited by 71
Candidemia in the Intensive Care Unit
Epelbaum, O., & Chasan, R. (2017) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2017.04.010 · Cited by 78
Al-Dorzi, H. M., Sakkijha, H., Khan, R., Aldabbagh, T., Toledo, A., Ntinika, P., Al Johani, S. M., & Arabi, Y. M. (2020) · Journal of Intensive Care Medicine · doi:10.1177/0885066618767835 · Cited by 61
Warrilow, A. G., Nishimoto, A. T., Parker, J. E., Price, C. L., Flowers, S. A., Kelly, D. E., Rogers, P. D., & Kelly, S. L. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02586-18 · Cited by 60
Azole‐resistant Candida spp. – emerging pathogens?
Tobudic, S., Kratzer, C., & Presterl, E. (2012) · Mycoses · doi:10.1111/j.1439-0507.2011.02146.x · Cited by 56
Sinnollareddy, M., Peake, S. L., Roberts, M. S., Lipman, J., & Roberts, J. A. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.07.013 · Cited by 56
Candida Bloodstream Infections: Changes in Epidemiology and Increase in Drug Resistance
Kotey, F. C. N., Dayie, N. T. K. D., Tetteh‐Quarcoo, P. B., & Donkor, E. S. (2021) · Infectious Diseases Research and Treatment · doi:10.1177/11786337211026927 · Cited by 77
Management of Sepsis and Septic Shock: What Have We Learned in the Last Two Decades?
Kamath, S., Altaq, H. H., & Abdo, T. (2023) · Microorganisms · doi:10.3390/microorganisms11092231 · Cited by 68
Chen, P., Chuang, Y., Wang, J., Sheng, W., Yu, C., Chu, C.-C., Hsueh, P., Chang, S., & Chen, Y. (2012) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2012.08.025 · Cited by 54
Candidaemia and a risk predictive model for overall mortality: a prospective multicentre study
Keighley, C., Chen, S. C. A., Marriott, D. J. E., Pope, A. L., Chapman, B., Kennedy, K., Bak, N., Underwood, N., Wilson, H. L., McDonald, K., et al. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-4065-5 · Cited by 54
Self-citationCentral venous catheter (CVC) removal for patients of all ages with candidaemia
Janum, S., & Afshari, A. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011195.pub2 · Cited by 58
Candida glabrata candidemia: An emerging threat in critically ill patients
Gupta, A., Varma, A., & Gupta, A. (2015) · Indian Journal of Critical Care Medicine · doi:10.4103/0972-5229.152757 · Cited by 50
Risk factors for candidaemia: A prospective multi‐centre case‐control study
Keighley, C., Pope, A., Marriott, D. J. E., Chapman, B., Bak, N., Daveson, K., Hajkowicz, K. M., Halliday, C. L., Kennedy, K., Kidd, S. E., et al. (2020) · Mycoses · doi:10.1111/myc.13211 · Cited by 48
Self-citationEffect of Usnic Acid on Candida orthopsilosis and C. parapsilosis
Pires, R. H., Lucarini, R., & Mendes‐Giannini, M. J. S. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05348-11 · Cited by 43
The Drosophila Toll Pathway Controls but Does Not Clear Candida glabrata Infections
Quintin, J., Asmar, J., Matskevich, A. A., Lafarge, M.-C., & Ferrandon, D. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201861 · Cited by 42
Prophylaxis, empirical and preemptive treatment of invasive candidiasis
Playford, E. G., Lipman, J., & Sorrell, T. C. (2010) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e32833e10e8 · Cited by 41
Self-citationКirov, М. Y., Владимирович, К. В., Николаевич, П. Д., Щеголев, А. В., Babaev, M. A., Belotserkovskiy, B. Z., Bykov, A. O., Gritsan, A. I., Кулабухов, В. В., Kulikov, A. V., et al. (2023) · Annals of critical care · doi:10.21320/1818-474x-2023-4-7-42 · Cited by 44
INVASIVE CANDIDIASIS IN NON-HEMATOLOGICAL PATIENTS.
Mikulska, M., Bassetti, M., Ratto, S., & Viscoli, C. (2011) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2011.007 · Cited by 37
Neoh, C. F., Liew, D., Slavin, M. A., Marriott, D., Chen, S. C. A., Morrissey, O., Stewart, K., & Kong, D. C. M. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr186 · Cited by 36
Self-citationEmergency medicine updates: Management of sepsis and septic shock
Long, B., & Gottlieb, M. A. (2025) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2025.01.054 · Cited by 34
Management of Invasive Candidiasis in the Intensive Care Unit
Playford, E. G., Lipman, J., & Sorrell, T. C. (2010) · Drugs · doi:10.2165/10898550-000000000-00000 · Cited by 30
Self-citationGriesser, S. S., Jasieniak, M., Coad, B. R., & Griesser, H. J. (2015) · Biointerphases · doi:10.1116/1.4933108 · Cited by 28
What was old is new again: using the host response to diagnose infectious disease
Ko, E. R., Yang, W. E., McClain, M. T., Woods, C. W., Ginsburg, G. S., & Tsalik, E. L. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2015.1059278 · Cited by 29
Li, Y., Wan, Z., Liu, W. Y., & Li, R. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04417-14 · Cited by 25
Ohki, S., Shime, N., Kosaka, T., & Fujita, N. (2020) · Journal of Intensive Care · doi:10.1186/s40560-020-00450-7 · Cited by 26
Shorr, A. F., Wu, C., & Kothari, S. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq446 · Cited by 24
Gómez, N. S., Torres, R. G., & López, C. C. O. (2017) · Nanotechnology Science and Applications · doi:10.2147/nsa.s96018 · Cited by 27
Candidaemia in the non-neutropenic patient: A critique of the guidelines
Deshpande, A., Gaur, S., & Bal, A. M. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.06.005 · Cited by 26
Alobaid, K., & Khan, Z. (2018) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2018.12.001 · Cited by 23
Zhang, M., Rao, Z.-G., Ma, T., Tang, M., Xu, T., He, X.-X., Li, Z.-P., Liu, Y., Xu, Q.-J., Yang, K., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.952611 · Cited by 19
Dimοpoulos, G., Paiva, J.-A., Meersseman, W., Pachl, J., Grigoraș, I., Sganga, G., Montravers, P., Auzinger, G. M., Sá, M. B., Miller, P. J., et al. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.07.018 · Cited by 17
Naderi, J., Giles, C., Saboohi, S., Griesser, H. J., & Coad, B. R. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky437 · Cited by 17
Kautzky, S., Staudinger, T., & Presterl, E. (2014) · Wiener klinische Wochenschrift · doi:10.1007/s00508-014-0644-z · Cited by 17
Rodrigues, C. F., Correia, A., Vilanova, M., & Henriques, M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8020142 · Cited by 16
Zaragoza, R., Llinares, P., Maseda, E., Ferrer, R., & Rodríguez, A. H. (2013) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2013.05.006 · Cited by 14
Design and use of Candida scores at the intensive care unit
Kratzer, C., Graninger, W., Lassnigg, A. M., & Presterl, E. (2011) · Mycoses · doi:10.1111/j.1439-0507.2010.01953.x · Cited by 18
Treviño‐Rangel, R. D. J., Espinosa-Pérez, J. F., Villanueva‐Lozano, H., Montoya, A. M., Andrade, Á., Bonifáz, A., & González, G. M. (2018) · Folia Microbiologica · doi:10.1007/s12223-018-0592-5 · Cited by 15
Nakada, N., Miyazaki, T., Ueda, T., Yamagishi, Y., Yamada, K., Kawamura, H., Kakeya, H., Mukae, H., Mikamo, H., Takesue, Y., et al. (2021) · Mycoses · doi:10.1111/myc.13380 · Cited by 14
Epidémiologie des candidoses invasives
Toubas, D. (2013) · Revue Francophone des Laboratoires · doi:10.1016/s1773-035x(13)71944-0 · Cited by 19
Candidemia in patients with prolonged fever in Kashan, Iran
Rezai, R., Momen–Heravi, M., Erami, M., & Nazeri, M. (2016) · Current Medical Mycology · doi:10.18869/acadpub.cmm.2.3.20 · Cited by 13
Cui, N., Wang, H., Qiu, H., Li, R., & Liu, D. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.02.019 · Cited by 13
Synthesis of new pyrazolo[5,1-c][1,2,4]triazines with antifungal and antibiofilm activities
Al‐Trawneh, S. A., Al-Dawdieh, S. A., Abutaleb, N. S., Tarawneh, A. H., Salama, E. A., El‐Abadelah, M. M., & Seleem, M. N. (2019) · Chemical Papers · doi:10.1007/s11696-019-00974-9 · Cited by 12
Lee, W., Liew, Y., Chlebicki, M. P., Ong, S. G. K., Lee, P., & Kwa, A. L. (2014) · Critical Care Research and Practice · doi:10.1155/2014/479413 · Cited by 14
Candidemia in the critically ill: initial therapy and outcome in mechanically ventilated patients
Ferrada, M. A., Quartin, A. A., Kett, D. H., & Morris, M. I. (2013) · BMC Anesthesiology · doi:10.1186/1471-2253-13-37 · Cited by 12
Candidemia in the intensive care unit: Miles to go before we sleep*
Pappas, P. G. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e31820f710b · Cited by 13
Neoh, C. F., Liew, D., Slavin, M. A., Marriott, D., Chen, S. C. ‐., Morrissey, O., Stewart, K., & Kong, D. C. M. (2013) · Mycoses · doi:10.1111/myc.12071 · Cited by 12
Self-citationWang, T., Hung, C., Shie, S., Chou, P.-C., Kuo, C. S., Chung, F., Lo, Y.-L., & Lin, S. (2016) · Medicine · doi:10.1097/md.0000000000003834 · Cited by 13
Diagnostic surveillance by Candida albicans germ tube antibody in intensive care unit patients
Trovato, L., Astuto, M., Castiglione, G., Scalia, G., & Oliveri, S. M. (2019) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2019.02.001 · Cited by 12
Clinical manifestations and prognostic factors of central line–associated candidemia
Tang, H.-J., Liu, W., Lin, H.-L., & Lai, C. (2014) · American Journal of Infection Control · doi:10.1016/j.ajic.2014.07.015 · Cited by 14
Epidemiology and Outcomes of Candidemia in a Referral Center in Tehran.
Salehi, M., Ghomi, Z., Mirshahi, R., Manshadi, S. A. D., & Rezahosseini, O. (2019) · PubMed Central · doi:10.22088/cjim.10.1.73 · Cited by 11
Camacho, A. M., & Ruíz-Camps, I. (2014) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2014.05.002 · Cited by 14
Pang, Y., Ip, M., & You, J. H. S. (2016) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-016-2796-4 · Cited by 12
Early-Onset Candidemia in Adult Intensive Care Units
Mouratidou, C., Tsakiri, K., Dourliou, V., Marneri, A. G., Stougianni, M., & Pavlidis, E. T. (2025) · Diagnostics · doi:10.3390/diagnostics15111402 · Cited by 10
Neoh, C. F., Liew, D., Slavin, M. A., Marriott, D., Chen, W., Morrissey, O., Stewart, K., & Kong, D. C. M. (2013) · Internal Medicine Journal · doi:10.1111/imj.12110 · Cited by 8
Self-citationCandidemia in the ICU: Does Initial Antifungal Matter?*
Bennett, J. E., & Powers, J. H. (2018) · Critical Care Medicine · doi:10.1097/ccm.0000000000002903 · Cited by 6
Mohammad, T. H. (2023) · IRAQI JOURNAL OF AGRICULTURAL SCIENCES · doi:10.36103/ijas.v54i4.1784 · Cited by 5
Role of oral nystatin prophylaxis in cardiac surgery with prolongedextracorporeal circulation
Russo, A., Carriero, G., Farcomeni, A., Ceccarelli, G., Tritapepe, L., & Venditti, M. (2017) · Mycoses · doi:10.1111/myc.12680 · Cited by 5
Zaragoza, R., Llinares, P., Maseda, E., Ferrer, R., & Rodríguez, A. H. (2013) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2013.05.005 · Cited by 4
Invasive Candidiasis in Patients with Implants
Shoham, S. (2010) · Current Fungal Infection Reports · doi:10.1007/s12281-010-0040-8 · Cited by 9
Year in review 2009: Critical Care - infection
Harbarth, S., & Haustein, T. (2010) · Critical Care · doi:10.1186/cc9268 · Cited by 6
Fungal infections in the critically ill
Dhillon, R. H., & Clark, J. (2011) · Trends in Anaesthesia and Critical Care · doi:10.1016/j.tacc.2011.05.007 · Cited by 4
Zou, Z.-Y., Sun, K.-J., Fu, G., Huang, J.-J., Yang, Z.-J., Zhou, Z.-P., Ma, S., Zhu, F., & Wu, M. T. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1047889 · Cited by 6
Tümtürk, A. (2020) · Journal of Surgery and Medicine · doi:10.28982/josam.686677 · Cited by 3
Zaragoza, R., Llinares, P., Maseda, E., Ferrer, R., & Rodríguez, A. H. (2013) · Revista Española de Anestesiología y Reanimación · doi:10.1016/j.redar.2013.05.016 · Cited by 3
Intravenous Sedatives and Anesthetics
McGrane, T. J., McEvoy, M. D., & Reves, J. G. (2017) · Springer eBooks · doi:10.1007/978-3-319-66878-9_17 · Cited by 3
Invasive Candidiasis in the Intensive Care Setting
GASPERI, A. D., Cozzi, P., & Colombo, S. (2013) · Springer eBooks · doi:10.1007/978-88-470-5529-2_13 · Cited by 1
Comportamiento de la candidemia en una unidad de cuidados intensivos
Muguercia, H. L., Serafín, Y. R., Posada, M. D. C. H., Costa, T. H., & Pérez, D. O. L. (2013) · Acta Médica · Cited by 1
[Current options for antifungal therapy of invasive candidiasis in intensive care units].
Hamal, P., Raclavský, V., Svobodová, L., & Koukalová, D. (2010) · PubMed
Bashir, M. R., & Webb, C. E. (2015)
Epidemiology and Outcome of Candidemia in ICU, Mashhad, a 6-Year Multi-Center Study
Bojdy, A., Ahrari, Y., Najafi, M. N., Arian, M., & Khosravi, N. (2022) · Pharmaceutics and Pharmacology Research · doi:10.31579/2693-7247/041
Haghighatfard, A., Abbasi, S., Alijani, P., Akbari, F. A., Rashidi, H., & Dehghan, P. (2022) · Current Medical Mycology · doi:10.18502/cmm.8.3.11217 · Cited by 1
Yoğun Bakım Hastalarının Kan Kültüründe Üreyen Candida Türlerinin Dağılımının Değerlendirilmesi
Günbey, F., Toraman, Z. A., Arslan, M. A., Baytaş, D. F., Bulut, Y., Şenol, F. F., & Akkaya, Y. (2022) · Mantar dergisi · doi:10.30708/mantar.1191002 · Cited by 1
Metadata
- Authors
- Marriott, D. J., Playford, E. G., Chen, S., Slavin, M., Nguyen, Q., Ellis, D., Sorrell, T. C., & Study, T. A. C.
- Affiliations
- UNSW Sydney (AU)
- The University of Sydney (AU)
- The Royal Melbourne Hospital (AU)
- St Vincent's Hospital Sydney (AU)
- Women's and Children's Hospital (AU)
- Corresponding author
- Playford, E Geoffrey
- Venue
- Critical Care
- Published
- 2009-07-13
- Volume
- 13
- Issue
- 4
- Pages
- R115-R115
- ISSN
- 1364-8535 (ISSN-L)
- PMC
- PMC2750162
- OpenAlex
- W2067245892
- Cited by
- 93
- References
- 25
- Citations by year
- 2026: 2 · 2025: 2 · 2023: 3 · 2022: 5 · 2021: 5 · 2020: 3 · 2019: 6 · 2018: 5 · 2017: 6 · 2016: 6 · 2015: 5 · 2014: 8 · 2013: 13 · 2012: 5
- FWCI
- 5.52
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/2.0/ (tdm)
- creativecommons.org/licenses/by/2.0/ (vor)
- Locations
- Critical Care (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- National University of Singapore (submittedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion, cc-by)
- Funders
- Pfizer
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections
- Keywords
- candidemia, non-neutropenic patients, mortality determinants, Candida albicans, Candida glabrata, fluconazole, antifungal therapy timing, host factors, mechanical ventilation, hemodialysis, central venous catheter removal, follow-up blood cultures, critically ill adults
- MeSH terms
- Aged, Aged, 80 and over, Australia, Candida, Candidiasis, Female, Humans, Male, Middle Aged, Neutropenia, Risk Factors, Species Specificity, Cohort Studies, Incidence, Fungemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.